A citation-based method for searching scientific literature

Ele Ferrannini, Simona Baldi, Silvia Frascerra, Brenno Astiarraga, Tim Heise, Roberto Bizzotto, Andrea Mari, Thomas R Pieber, Elza Muscelli. Diabetes 2016
Times Cited: 259



Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann, Waheed Jamal, Karen Kimura, Janet Schnee, Cordula Zeller, Daniel Cotton, Edimar Bocchi, Michael Böhm, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure, Nadia Giannetti, Stefan Janssens, Jian Zhang, Jose R Gonzalez Juanatey, Sanjay Kaul, Hans-Peter Brunner-La Rocca, Bela Merkely, Stephen J Nicholls, Sergio Perrone, Ileana Pina, Piotr Ponikowski, Naveed Sattar, Michele Senni, Marie-France Seronde, Jindrich Spinar, Iain Squire, Stefano Taddei, Christoph Wanner, Faiez Zannad. N Engl J Med 2020
Times Cited: 492




List of shared articles



Times cited

Myocardial ketone body utilization in patients with heart failure: The impact of oral ketone ester.
Luca Monzo, Kamil Sedlacek, Katarina Hromanikova, Lucie Tomanova, Barry A Borlaug, Antonin Jabor, Josef Kautzner, Vojtech Melenovsky. Metabolism 2021
4

SGLT2-inhibitors; more than just glycosuria and diuresis.
Amir Fathi, Keeran Vickneson, Jagdeep S Singh. Heart Fail Rev 2021
3

A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.
Shigenori Hiruma, Fumika Shigiyama, Shinji Hisatake, Sunao Mizumura, Nobuyuki Shiraga, Masaaki Hori, Takanori Ikeda, Takahisa Hirose, Naoki Kumashiro. Cardiovasc Diabetol 2021
5

Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy.
Biff F Palmer, Deborah J Clegg. Clin J Am Soc Nephrol 2021
1

The "discordant doppelganger dilemma": SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma?
Scott W Murray, Sean McKelvey, Thomas D Heseltine, George Henderson, Jagdeep Singh, David Unwin, Adrian J B Brady. J Hum Hypertens 2021
0

Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review.
Salva R Yurista, Cher-Rin Chong, Juan J Badimon, Daniel P Kelly, Rudolf A de Boer, B Daan Westenbrink. J Am Coll Cardiol 2021
6

SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta-analysis.
Yuling Yan, Bin Liu, Jun Du, Jing Wang, Xiaodong Jing, Yajie Liu, Songbai Deng, Jianlin Du, Qiang She. ESC Heart Fail 2021
3


Sodium-glucose transporter inhibition in heart failure: from an unexpected side effect to a novel treatment possibility.
Giulia Ferrannini, Gianluigi Savarese, Lars Rydén. Diabetes Res Clin Pract 2021
0

Empagliflozin Disrupts a Tnfrsf12a-Mediated Feed Forward Loop That Promotes Left Ventricular Hypertrophy.
Veera Ganesh Yerra, Sri Nagarjun Batchu, Golam Kabir, Suzanne L Advani, Youan Liu, Ferhan S Siddiqi, Kim A Connelly, Andrew Advani. Cardiovasc Drugs Ther 2021
0


Recent advances in pharmacological treatment of heart failure.
Massimo Iacoviello, Alberto Palazzuoli, Edoardo Gronda. Eur J Clin Invest 2021
0

An evaluation of canagliflozin for the treatment of type 2 diabetes: an update.
Taichi Minami, Akiko Kameda, Yasuo Terauchi. Expert Opin Pharmacother 2021
0

Rationale and design of the randomised controlled cross-over trial: Cardiovascular effects of empaglifozin in diabetes mellitus.
Sharmaine Thirunavukarasu, Louise Ae Brown, Amrit Chowdhary, Nicholas Jex, Peter Swoboda, John P Greenwood, Sven Plein, Eylem Levelt. Diab Vasc Dis Res 2021
0

Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitors.
William G Herrington, Gianluigi Savarese, Richard Haynes, Nikolaus Marx, Linda Mellbin, Lars H Lund, Paul Dendale, Petar Seferovic, Giuseppe Rosano, Natalie Staplin,[...]. Eur J Heart Fail 2021
0

Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms.
Lei Xiao, Xin Nie, Yanyan Cheng, Nanping Wang. Cardiovasc Drugs Ther 2021
0

SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: A systematic review and meta-analysis.
Rhanderson Cardoso, Fabrissio P Graffunder, Caique M P Ternes, Amanda Fernandes, Ana V Rocha, Gilson Fernandes, Deepak L Bhatt. EClinicalMedicine 2021
0